During the past decade, Bay Area Cancer Research Group conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bay Area Cancer Research Group" #1 sponsor was "Novartis Pharmaceuticals" with 6 trials, followed by "Telik" with 5 trials sponsored, "Eisai Inc." with 2 trials sponsored, "Genentech, Inc." with 2 trials sponsored and "Tragara Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bay Area Cancer Research Group" #1 collaborator was "Astex Pharmaceuticals, Inc." with 1 trials as a collaborator, "Mena, Raul, M.D." with 1 trials as a collaborator, "Pharmatech Oncology" with 1 trials as a collaborator, "Quintiles, Inc." with 1 trials as a collaborator and "University of Chicago" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Bay Area Cancer Research Group" are "Breast Cancer" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Ovarian Neoplasms" (2 trials), "Breast Neoplasms" (1 trials) and "Carcinoma, Renal Cell" (1 trials). Many other conditions were trialed in "Bay Area Cancer Research Group" in a lesser frequency.

Most popular intervention types in "Bay Area Cancer Research Group" are "Drug" (23 trials). Other intervention types were less common.

The name of intervention was led by "Avastin (bevacizumab)" (2 trials), "Tarceva (erlotinib HCl)" (2 trials), "carboplatin" (2 trials), "paclitaxel" (2 trials) and "zoledronic acid" (2 trials). Other intervention names were less common.

The vast majority of trials in "Bay Area Cancer Research Group" are 19 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Bay Area Cancer Research Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Bay Area Cancer Research Group, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Bay Area Cancer Research Group, 3 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".